Marrone Bio Innovations Company Profile (NASDAQ:MBII)

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company's bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It offers Regalia for large-acre row crops, such as corn and soybeans. Its pipeline of early-stage discoveries and product candidates extends across a range of product types for end markets, including herbicides, fungicides, nematicides, insecticides, algaecides (for algae control), molluscicides (for mussel and snail control), and plant growth and plant stress regulators. It is engaged in developing MBI-010, MBI-110, Haven (MBI-505) and MBI-601.

Industry, Sector and Symbol:

Sector: Basic Materials
Industry: Agricultural Chemicals
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: MBII
CUSIP:

Key Metrics:

Previous Close: $1.78
50 Day Moving Average: $1.39
200 Day Moving Average: $0.98
52-Week Range: $0.60 - $4.00
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -2.37
P/E Growth: 0.00
Market Cap: $43.82M
Outstanding Shares: 24,619,000
Beta: 0.57

Profitability:

Net Margins: -304.71%
Return on Equity: -2,083.14%
Return on Assets: -53.84%

Debt:

Debt-to-Equity Ratio: -3.46%
Current Ratio: 2.75%
Quick Ratio: 2.17%

Additional Links:

Companies Related to Marrone Bio Innovations:

Consensus Ratings for Marrone Bio Innovations (NASDAQ:MBII) (?)

Ratings Breakdown:	1 Hold Rating, 3 Buy Ratings
Consensus Rating:	Buy (Score: 2.75)
Consensus Price Target:	$5.06 (184.41% upside)

Analysts' Ratings History for Marrone Bio Innovations (NASDAQ:MBII)

Show:

Date	Firm	Action	Rating	Price Target
5/17/2016	Jefferies Group	Reiterated Rating	Hold	$1.00 -> $0.75
5/14/2016	Piper Jaffray Cos.	Reiterated Rating	Overweight	$2.00 -> $1.00
3/16/2016	HC Wainwright	Reiterated Rating	Buy
3/16/2016	Rodman & Renshaw	Initiated Coverage	Buy	$3.50
12/31/2015	Roth Capital	Reiterated Rating	Buy -> Not Rated	$15.00

(Data available from 9/24/2014 forward)

Earnings History for Marrone Bio Innovations (NASDAQ:MBII)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/15/2016
8/9/2016	Q216	($0.28)	($0.28)	$4.61 million	$5.00 million	View	N/A
5/12/2016	Q116	($0.27)	($0.38)	$3.05 million	$2.70 million	View	Listen
3/30/2016	Q215	($0.40)	($0.45)	$1.10 million	$1.90 million	View	Listen
8/7/2014		($0.47)	($0.50)			View	N/A
5/13/2014	Q114	($0.38)	($0.52)	$4.63 million	$2.80 million	View	N/A
3/6/2014		($0.40)	($0.52)			View	N/A
9/12/2013	Q2 2013	($0.33)	($2.36)	$4.33 million	$4.50 million	View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Marrone Bio Innovations (NASDAQ:MBII)

Current Year EPS Consensus Estimate: $-1.12 EPS
Next Year EPS Consensus Estimate: $-0.75 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q3 2016	1	($0.29)	($0.29)	($0.29)
Q4 2016	1	($0.35)	($0.35)	($0.35)

(Data provided by Zacks Investment Research)

Dividend History for Marrone Bio Innovations (NASDAQ:MBII)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Marrone Bio Innovations (NASDAQ:MBII)

Insider Ownership Percentage: 7.25%
Institutional Ownership Percentage: 40.64%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
6/15/2016	Richard E Rominger	Director	Buy	10,000	$0.94	$9,400.00
6/13/2016	James Boyd	CFO	Buy	10,000	$0.79	$7,900.00
6/9/2016	George H Kerckhove	Director	Buy	2,500	$0.72	$1,800.00
6/9/2016	Pamela G Marrone	CEO	Buy	5,000	$0.72	$3,600.00
6/9/2016	Timothy B Johnson	VP	Buy	10,000	$0.72	$7,200.00
8/14/2014	George H Kerckhove	Director	Buy	400	$5.90	$2,360.00
8/12/2014	Pamela G Marrone	CEO	Buy	1,000	$5.29	$5,290.00
2/12/2014	Ventures Pte. Ltd. Syngenta	major shareholder	Sell	332,027	$14.72	$4,887,437.44
1/29/2014	Donald Glidewell	CFO	Sell	75,495	$17.00	$1,283,415.00

(Data available from 1/1/2013 forward)

Latest Headlines for Marrone Bio Innovations (NASDAQ:MBII)

Date	Headline
	Marrone Bio Innovations : rsquo; Majestene Bionematicide Awarded Best New Biopesticide in 2016 Agrow Awards (NASDAQ:MBII) www.4-traders.com - September 22 at 10:51 AM
	Marrone Bio Innovations’ Majestene Bionematicide Awarded Best New Biopesticide in 2016 Agrow Awards (NASDAQ:MBII) uk.finance.yahoo.com - September 22 at 10:51 AM
	ETF’s with exposure to Marrone Bio Innovations, Inc. : September 21, 2016 (NASDAQ:MBII) www.capitalcube.com - September 21 at 5:46 PM
	Bayer-Monsanto deal could have repercussions in Sacramento region (NASDAQ:MBII) www.bizjournals.com - September 15 at 9:12 PM
	Marrone Bio Innovations : Hires New Manager for Latin America Business (NASDAQ:MBII) www.4-traders.com - September 15 at 9:12 PM
	Marrone Bio Innovations Hires New Manager for Latin America Business (NASDAQ:MBII) finance.yahoo.com - September 13 at 10:54 AM
	ETF’s with exposure to Marrone Bio Innovations, Inc. : September 8, 2016 (NASDAQ:MBII) www.capitalcube.com - September 8 at 5:52 PM
	Marrone Bio Innovations to Webcast its Presentation at the Rodman & Renshaw 18th Annual Global Investment Conference (NASDAQ:MBII) finance.yahoo.com - September 6 at 10:47 AM
	Marrone Bio Innovations : Mexico’s Aneberries Adds Two Marrone Bioinsecticides to Approved Products Lists (NASDAQ:MBII) www.4-traders.com - September 1 at 9:09 AM
	Mexico’s Aneberries Adds Two Marrone Bioinsecticides to Approved Products Lists (NASDAQ:MBII) www.publicnow.com - August 30 at 6:03 PM
	Marrone Bio Innovations : Mexico's Aneberries Adds Two Marrone Bioinsecticides to Approved Products Lists (NASDAQ:MBII) www.4-traders.com - August 29 at 10:39 AM
	Mexico's Aneberries Adds Two Marrone Bioinsecticides to Approved Products Lists (NASDAQ:MBII) finance.yahoo.com - August 29 at 10:39 AM
	MARRONE BIO INNOVATIONS INC Financials (NASDAQ:MBII) finance.yahoo.com - August 24 at 5:55 PM
	ETF’s with exposure to Marrone Bio Innovations, Inc. : August 22, 2016 (NASDAQ:MBII) www.capitalcube.com - August 22 at 6:04 PM
	Marrone Bio shares double in week since earnings report (NASDAQ:MBII) www.bizjournals.com - August 20 at 10:11 AM
	Marrone Bio Innovations, Inc. :MBII-US: Earnings Analysis: Q2, 2016 By the Numbers : August 19, 2016 (NASDAQ:MBII) www.capitalcube.com - August 19 at 6:01 PM
	Improved performance propels Marrone Bio; shares up 93% in five trading days (NASDAQ:MBII) seekingalpha.com - August 17 at 6:17 PM
	MARRONE BIO INNOVATIONS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:MBII) biz.yahoo.com - August 15 at 6:16 PM
	Marine Bio (MBII) Reports In-Line Q2 EPS, Enters Microbial Product Development Pact with Albaugh (NASDAQ:MBII) www.streetinsider.com - August 11 at 9:14 AM
	Marrone Bio Innovations, Inc Reports Second Quarter 2016 Results (NASDAQ:MBII) www.biospace.com - August 11 at 9:14 AM
	Marrone Bio Innovations' (MBII) CEO Pam Marrone on Q2 2016 Results - Earnings Call Transcript (NASDAQ:MBII) seekingalpha.com - August 11 at 9:14 AM
	Davis biotech firm Marrone reduces losses as sales grow (NASDAQ:MBII) www.sacbee.com - August 9 at 6:19 PM
	Marrone Bio's loss narrows as sales rise 50 percent (NASDAQ:MBII) www.bizjournals.com - August 9 at 6:19 PM
	Albaugh and Marrone Bio Innovations Sign Exclusive Seed Treatment Agreement for a Microbial Biopesticide Product (NASDAQ:MBII) www.businesswire.com - August 9 at 6:19 PM
	Marrone Bio Innovations Reports Second Quarter 2016 Results (NASDAQ:MBII) finance.yahoo.com - August 9 at 6:19 PM
	MARRONE BIO INNOVATIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a (NASDAQ:MBII) biz.yahoo.com - August 9 at 6:19 PM
	Marrone Bio Innovations to Webcast its Presentation at the Jefferies 2016 Global Industrials Conference (NASDAQ:MBII) finance.yahoo.com - August 4 at 9:13 AM
	Marrone Bio Investors Say Ernst & Young Must Face Claims (NASDAQ:MBII) www.law360.com - August 2 at 6:23 PM
	Marrone Bio Innovations Announces Date for Second Quarter 2016 Financial Results (NASDAQ:MBII) finance.yahoo.com - August 2 at 6:23 PM
	U.S.: Mexican market opens up for Marrone bioinsecticides (NASDAQ:MBII) www.freshfruitportal.com - July 28 at 6:18 PM
	Marrone Bio Innovations receive registration for two bioinsecticides in Mexico (NASDAQ:MBII) www.agprofessional.com - July 28 at 6:18 PM
	Marrone Bio Innovations Receives Registration for Grandevo and Venerate Bioinsecticides in Mexico (NASDAQ:MBII) www.businesswire.com - July 26 at 9:16 AM
	Marrone Bio Innovations : Regalia Biofungicide Products Approved for Home and Garden Uses in Canada (NASDAQ:MBII) www.4-traders.com - July 18 at 6:15 PM
	Marrone Bio Innovations to Speak at Crops and Chemicals 2016 Conference (NASDAQ:MBII) finance.yahoo.com - July 18 at 10:00 AM
	Regalia Biofungicide Products Approved for Home and Garden Uses in Canada (NASDAQ:MBII) www.wallstreet-online.de - July 14 at 6:20 PM
	Marrone Bio Innovations : Davis biotech firm might accept stock market downgrade (NASDAQ:MBII) www.4-traders.com - July 13 at 6:28 PM
	With another warning from Nasdaq, Marrone Bio remains focused on growth, founder says (NASDAQ:MBII) www.bizjournals.com - July 13 at 6:28 PM
	MARRONE BIO INNOVATIONS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or (NASDAQ:MBII) biz.yahoo.com - July 12 at 5:17 PM
	Moroccan Biostimulant and Biopesticide Markets - Key Players are Isagro SPA, Marrone Bio Innovations & Bayer CropScience AG - Research and Markets (NASDAQ:MBII) finance.yahoo.com - July 12 at 10:28 AM
	Marrone Bio Innovations Incorporated (NASDAQ:MBII) Shorted Shares Increased By 7.39% - Engelwood Daily (NASDAQ:MBII) www.engelwooddaily.com - June 29 at 8:55 AM
	Marrone Bio Innovations and Groundwork BioAg Sign Seed Treatment Development Agreement - Business Wire (press release) (NASDAQ:MBII) www.businesswire.com - June 29 at 8:55 AM
	Marrone Bio, Israeli company working on "world's first" all-biologic, comprehensive seed treatment (NASDAQ:MBII) www.bizjournals.com - June 28 at 5:55 PM
	Marrone Bio Innovations and Groundwork BioAg Sign Seed Treatment Development Agreement (NASDAQ:MBII) www.publicnow.com - June 28 at 10:31 AM
	Marrone Bio Innovations Incorporated (NASDAQ:MBII) Short Interest Increased By 0.3% - Engelwood Daily (NASDAQ:MBII) www.engelwooddaily.com - June 24 at 8:45 AM
	Marrone Bio Innovations, Inc. (MBII) Current Analyst Ratings - Fiscal Standard (NASDAQ:MBII) www.fiscalstandard.com - June 22 at 10:49 AM
	This Weeks Broker Views For Marrone Bio Innovations, Inc. (MBII) - Fiscal Standard (NASDAQ:MBII) www.fiscalstandard.com - June 20 at 7:17 AM
	Basic Material Unusual Volume: Axiall Corporation (NYSE:AXLL), Marrone Bio Innovations (NASDAQ:MBII), Houston ... - KC Register (NASDAQ:MBII) www.kcregister.com - June 15 at 10:42 AM
	Marrone Bio Innovations Inc. (MBII) Jumps 5.22% on June 13 - Equities.com (NASDAQ:MBII) www.equities.com - June 15 at 10:42 AM
	Marrone Bio Innovations : New Formulation Grandevo WDG Bioinsecticide Now Available from Marrone Bio Innovations (NASDAQ:MBII) www.4-traders.com - June 13 at 5:45 PM
	New Formulation Grandevo WDG Bioinsecticide Now Available from Marrone Bio Innovations (NASDAQ:MBII) www.publicnow.com - June 13 at 12:29 PM